KURA

Kura Oncology, Inc.

NasdaqHealthcarePharmaceutical Preparations

Insider activity for last month from 09/27 to 10/27.

How these metrics are calculated

Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Total buying$00 buys
Total selling$1.03M9 sells
Net open-market−$1.03MBuying minus selling
Active insiders5Distinct reporting owners

Insider activity report

Calendar-month buckets within the selected date range

Latest filing: Sep 29, 2026

Open-market transaction mix · 9 transactions in the selected period
0 buys0%·100%9 sells

Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.

View exact monthly counts and disclosed values
Monthly activity within the selected period; unknown values remain unknown.
MonthBuysSellsAwards (A)Buy valueSell valueNet P/S value
Sep 2026090$0$1.03M-$1.03M
Oct 2026000$0$0$0

Distinct insiders active

Reporting-owner CIKs by month · peak Sep 2026 (5)
Sep 2026: 5 insidersOct 2026: 0 insiders
Sep 2026Oct 2026
5distinct insiders in selected period
Largest insider activity
By absolute net disclosed value · current transaction page
5 insiders
  • LM
    Leoni MollieCMO · 0 buys · 2 sells · 0 awards (A)
    -$440.2klast 09/29/2026
  • PT
    Powl Brian T.CCO · 0 buys · 3 sells · 0 awards (A)
    -$345.0klast 09/29/2026
  • FK
    Ford KathleenCOO · 0 buys · 2 sells · 0 awards (A)
    -$111.9klast 09/29/2026
  • BB
    Bair Teresa BrophyCLO · 0 buys · 1 sells · 0 awards (A)
    -$88.6klast 09/29/2026
  • DJ
    Doyle Thomas JamesSVP · 0 buys · 1 sells · 0 awards (A)
    -$48.4klast 09/29/2026

KURA transaction history

Newest filings · 20 transactions per page

Latest insider transactions

Form 4 filings from last month.
Newest company filings
CompanyInsiderActivityDisclosed valueFiled (ET)
KURAKura Oncology, Inc.
Bair Teresa BrophyCLOS · saleSEC filing ↗-$88.6kView disclosure →
KURAKura Oncology, Inc.
Ford KathleenCOOS · sale10b5-1 detectedSEC filing ↗-$39.4kView disclosure →
KURAKura Oncology, Inc.
Ford KathleenCOOS · sale10b5-1 detectedSEC filing ↗-$72.4kView disclosure →
KURAKura Oncology, Inc.
Leoni MollieCMOS · sale10b5-1 detectedSEC filing ↗-$309kView disclosure →
KURAKura Oncology, Inc.
Leoni MollieCMOS · sale10b5-1 detectedSEC filing ↗-$130kView disclosure →
KURAKura Oncology, Inc.
Doyle Thomas JamesSVPS · saleSEC filing ↗-$48.3kView disclosure →
KURAKura Oncology, Inc.
Powl Brian T.CCOS · sale10b5-1 detectedSEC filing ↗-$165kView disclosure →
KURAKura Oncology, Inc.
Powl Brian T.CCOS · sale10b5-1 detectedSEC filing ↗-$84.4kView disclosure →
KURAKura Oncology, Inc.
Powl Brian T.CCOS · sale10b5-1 detectedSEC filing ↗-$94.6kView disclosure →

Filing-only signals

Deterministic matches in the selected period

Recent filing activity
Most recent 6 transactions on this page · color = transaction code

Filing detail checks

Secondary metrics for the selected period
Largest buy-
Largest sale$309k
10b5-1 detected7
Amended rows0

Transaction codes

By Form 4 transaction code in selected period
9transactionstxns
  • S · Open-market sells · dominant9 · 100%

Activity by reported role

A joint filing can contribute to multiple roles
CCO3
CMO2
COO2
CLO1
SVP1

Reported Holdings After

Separated by insider, security, and ownership type

Powl Brian T.Common Stock · Direct
160.2k136.8kSep 28, 2026Sep 29, 2026
136,819Sep 29, 2026
Leoni MollieCommon Stock · Direct
169.9k141.1kSep 28, 2026Sep 29, 2026
141,095Sep 29, 2026
Ford KathleenCommon Stock · Direct
146.7k143.0kSep 28, 2026Sep 29, 2026
142,986Sep 29, 2026
Doyle Thomas JamesCommon Stock · Direct
142.4k142.4kSep 28, 2026Sep 28, 2026
142,428Sep 28, 2026
Bair Teresa BrophyCommon Stock · Direct
187.0k187.0kSep 28, 2026Sep 28, 2026
187,002Sep 28, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells red
1 active days
Sep 27 → Oct 27
LessMore

Kura Oncology, Inc. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at Kura Oncology, Inc.?

Bair Teresa Brophy, FORD KATHLEEN, Leoni Mollie, DOYLE THOMAS JAMES, Powl Brian T..

When was the latest reported open-market purchase?

No code-P purchase is available for this period.

When was the latest reported open-market sale?

Ford Kathleen reported a sale on Sep 29, 2026 valued at $39.4k. Read the SEC filing.

What is the recent purchase and sale balance?

Net open-market selling in the selected period was $1,034,182.89. Sales can occur for many non-investment reasons.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.